Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Lampasona

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Clinics in Laboratory Medicine|September 1, 1987
Monitoring aminoglycoside therapyR E Mullins, V Lampasona, R B Conn
American Journal of Hospital Pharmacy|April 1, 1986
Stability of ranitidine admixtures frozen and refrigerated in minibagsV Lampasona, R E Mullins, R B Parks
American Journal of Hospital Pharmacy|April 1, 1990
Pharmacokinetics-monitoring formV Lampasona, W H Asbury, R E Mullins
Clinical Pharmacokinetics|September 1, 1993
Computers in pharmacokinetics. Choosing software for clinical decision makingD E Buffington, V Lampasona, M H Chandler
Topics in Hospital Pharmacy Management|March 9, 1994
The financial impact of investigational drug servicesS D Rogers, V Lampasona, E C Buchanan
Lancet (London, England)|October 20, 1998
Tissue transglutaminase and combined screening for coeliac disease and type 1 diabetes-associated autoantibodiesV Lampasona, E Bazzigaluppi, G Barera, et al.
Diabetes|June 27, 2000
Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetesE Bonifacio, V Lampasona, L Bernasconi, et al.
Biotechniques|July 1, 1993
Lyophilization as a method to store samples of whole bloodE P Weisberg, R Giorda, M Trucco, et al.
American Journal of Hospital Pharmacy|December 1, 1985
Stability of ranitidine hydrochloride and amino acids in parenteral nutrient solutionsL Bullock, R B Parks, V Lampasona, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1995
Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodiesE Bonifacio, V Lampasona, S Genovese, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Clinics in Laboratory Medicine|September 1, 1987
Monitoring aminoglycoside therapyR E Mullins, V Lampasona, R B Conn
American Journal of Hospital Pharmacy|April 1, 1986
Stability of ranitidine admixtures frozen and refrigerated in minibagsV Lampasona, R E Mullins, R B Parks
American Journal of Hospital Pharmacy|April 1, 1990
Pharmacokinetics-monitoring formV Lampasona, W H Asbury, R E Mullins
Clinical Pharmacokinetics|September 1, 1993
Computers in pharmacokinetics. Choosing software for clinical decision makingD E Buffington, V Lampasona, M H Chandler
Topics in Hospital Pharmacy Management|March 9, 1994
The financial impact of investigational drug servicesS D Rogers, V Lampasona, E C Buchanan
Lancet (London, England)|October 20, 1998
Tissue transglutaminase and combined screening for coeliac disease and type 1 diabetes-associated autoantibodiesV Lampasona, E Bazzigaluppi, G Barera, et al.
Diabetes|June 27, 2000
Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetesE Bonifacio, V Lampasona, L Bernasconi, et al.
Biotechniques|July 1, 1993
Lyophilization as a method to store samples of whole bloodE P Weisberg, R Giorda, M Trucco, et al.
American Journal of Hospital Pharmacy|December 1, 1985
Stability of ranitidine hydrochloride and amino acids in parenteral nutrient solutionsL Bullock, R B Parks, V Lampasona, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1995
Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodiesE Bonifacio, V Lampasona, S Genovese, et al.
Pageof 6